Fig. 4From: Cost-utility analysis of palonosetron in the antiemetic regimen for cisplatin-containing highly emetogenic chemotherapy in JapanCost-effectiveness acceptability curve for probabilistic sensitivity analyses. PALO: palonosetron; GRA: granisetron; JPY: Japanese yenBack to article page